Want to see TSE:HEAL full AI Analyst Report?
Restart Life Sciences (HEAL) Stock Forecast & Price Target
HEAL Analyst Ratings
There are no analyst ratings in the last 3 months.
HEAL Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | CAD 0.08→CAD 0.06 | sell | -23.75%Downside | Downgraded | 10/30/26 | ||
| Google Biotechnology | TipRanks - Google | CAD 0.07→CAD 0.06 | sell | -22.50%Downside | Reiterated | 10/30/26 | ||
| Anthropic Biotechnology | TipRanks - Anthropic | CAD 0.07→CAD 0.06 | sell | -23.75%Downside | Reiterated | 10/30/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | CAD 0.07→CAD 0.06 | hold | -22.50%Downside | Upgraded | 10/30/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | CAD 0.07→CAD 0.06 | sell | -23.75%Downside | Downgraded | 10/30/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | CAD 0.08→CAD 0.06 | sell | -23.75%Downside | Reiterated | 10/30/26 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 10/30/26 | CAD 0.08→CAD 0.06 | sell | -23.75%Downside | Downgraded | TipRanks - PerPlexity | ||
| Google Biotechnology | 10/30/26 | CAD 0.07→CAD 0.06 | sell | -22.50%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Biotechnology | 10/30/26 | CAD 0.07→CAD 0.06 | sell | -23.75%Downside | Reiterated | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 10/30/26 | CAD 0.07→CAD 0.06 | hold | -22.50%Downside | Upgraded | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 10/30/26 | CAD 0.07→CAD 0.06 | sell | -23.75%Downside | Downgraded | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 10/30/26 | CAD 0.08→CAD 0.06 | sell | -23.75%Downside | Reiterated | TipRanks - xAI |
HEAL Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, HEAL has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HEAL average Analyst price target in the past 3 months is ―.
HEAL Financial Forecast
HEAL Earnings Forecast
Next quarter’s earnings estimate for HEAL is -CAD 0.02 with a range of ― to ―. The previous quarter’s EPS was -CAD 0.02. HEAL beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year HEAL has Performed in-line its overall industry.
HEAL Sales Forecast
Next quarter’s sales forecast for HEAL is CAD 331.16K with a range of ― to ―. The previous quarter’s sales results were CAD 331.16K. HEAL beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year HEAL has Performed in-line its overall industry.